Nippon India Pharma Fund vs UTI Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹7404 Cr | ₹986 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 01 Jun 2004 | 05 Aug 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.82 | 2.29 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Exit load of 1% if redeemed within 1 month./365 | Exit load of 1% if redeemed within 30 days./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -4.24% | -3.23% |
| 6 Month | 15.32% | 23.82% |
| 1 Year | 35.43% | 44.13% |
| 3 Year | 18.33% | 19.71% |
| 5 Year | 26.98% | 26.97% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 31.44% | 45.07% |
| 3 Year | 30.78% | 34.39% |
| 5 Year | 25.57% | 26.61% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 17.79% | 10.93% |
| 3 Year | 20.87% | 15.88% |
| 5 Year | 20.18% | 14.02% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.36% | 14.3% |
| Sharp | 0.68% | 0.62% |
| Beta | 0.91% | 0.94% |
| Alpha | 1.57% | 0.78% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Fund Manage | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.4 | 2.21 |
| Large Cap | 45.96 | 33.75 |
| Mid Cap | 27.12 | 31.32 |
| Small Cap | 22.52 | 32.72 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.4 | 0.97 |
| Pharmaceuticals & Biotechnology | 75.86 | - |
| Healthcare Services | 17.38 | - |
| Retailing | 2.36 | - |
| Financial | - | 0.13 |
| Healthcare | - | 97.31 |
| Insurance | - | 1.59 |
Top Comparisons
Canara Robeco Overnight Fund - Regular Plan - Growth Option
3Y Returns5.83%
Sundaram Overnight Fund Regular Plan - Growth
3Y Returns5.79%
SBI Liquid Fund - Regular Plan -Growth
3Y Returns6.19%
HSBC Liquid Fund - Regular Growth
3Y Returns6.25%
Tata Banking & PSU Debt Fund-Regular Plan-Growth
3Y Returns4.97%
Mirae Asset Banking and PSU Fund Regular Growth Plan
3Y Returns5.39%
UTI - Overnight Fund - Regular Plan - Growth Option
3Y Returns5.85%
Quant Overnight Fund Regular - Growth
3Y Returns0%